Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

BIAF bioAffinity Technologies

2.900
+0.140+5.07%
Close 10/06 16:00 ET
2.800
-0.100-3.45%
Post Mkt Price 10/06 17:03 ET
High
3.050
Open
2.730
Turnover
644.88K
Low
2.650
Pre Close
2.760
Volume
222.83K
Market Cap
11.63M
P/E(TTM)
Loss
52wk High
15.550
Shares
4.01M
P/E(Static)
Loss
52wk Low
2.021
Float Cap
3.72M
Bid/Ask %
-60.00%
Historical High
15.550
Shs Float
1.28M
Volume Ratio
0.44
Historical Low
2.021
Dividend TTM
--
Div Yield TTM
--
P/B
-0.69
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
17.37%
Amplitude
14.49%
Avg Price
2.894
Lot Size
1
Float Cap
3.72M
Bid/Ask %
-60.00%
Historical High
15.550
Shs Float
1.28M
Volume Ratio
0.44
Historical Low
2.021
Dividend TTM
--
P/B
-0.69
Dividend LFY
--
Turnover Ratio
17.37%
Amplitude
14.49%
Avg Price
2.894
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
CEO: Ms. Maria Zannes, J.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...